Clinical and Experimental Pharmacology and Physiology

Effects of calcitriol on the immune system: new possibilities in the treatment of glomerulonephritis
pp. 807-811(5)
Authors: Panichi V.; Migliori M.; Taccola D.; Consani C.; Giovannini L.

Lipoxygenase and cyclo-oxygenase products in the control of regional kidney blood flow in rabbits
pp. 812-819(8)
Authors: Oliver J.J.; Eppel G.A.; Rajapakse N.W.; Evans R.G.

Effect of cross-fostering on blood pressure and renal function in the New Zealand genetically hypertensive rat
pp. 820-826(7)
Authors: Ashton N.; Kelly P.; Ledingham J.M.

Effects of losartan on pressure overload-induced cardiac gene expression profiling in rats
pp. 827-832(6)
Authors: Li J.; Li P.; Feng X.; Li Z.; Hou R.; Han C.; Zhang Y.

Science and physicianly practice: Are they compatible?
pp. 833-835(3)
Author: Seale J.P.

In silico insights: Chemical and structural characteristics associated with uridine diphosphate-glucuronosyltransferase substrate selectivity
pp. 836-840(5)
Authors: Smith P.; Sorich M.; McKinnon R.; Miners J.

Experimental therapeutics of Parkinson's disease
pp. 841-844(4)
Author: Henderson J.M.

Oxidative metabolism of tamoxifen to Z-4-hydroxy-tamoxifen by cytochrome P450 isoforms: An appraisal of in vitro studies
pp. 845-848(4)
Author: Coller J.

Novel isoforms of NADPH oxidase in vascular physiology and pathophysiology
pp. 849-854(6)
Authors: Bengtsson S.H.; Gulluyan L.M.; Dusting G.J.; Drummond G.R.

Cerebral vascular effects of reactive oxygen species: Recent evidence for a role of NADPH-oxidase
pp. 855-859(5)
Authors: Paravicini T.M.; Sobey C.G.

Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension
pp. 860-866(7)
Authors: Touyz R.M.; Tabet F.; Schiffrin E.L.

Mouse isolated perfused heart: Characteristics and cautions
pp. 867-878(12)
Authors: Sutherland F.J.; Shattock M.J.; Baker K.E.; Hearse D.J.

Responses to ischaemia and reperfusion in the mouse isolated perfused heart and the phenomenon of ‘contractile cycling’
pp. 879-884(6)
Authors: Sutherland F.J.; Baker K.E.; Shattock M.J.; Hearse D.J.

Neurocardiovascular regulation in mice: Experimental approaches and novel findings
pp. 885-893(9)
Authors: Ma X.; Abboud F.M.; Chapleau M.W.

Activin and TR3 orphan receptor: Two ‘atheroprotective’ genes as evidenced in dedicated mouse models
pp. 894-899(6)
Authors: Engelse M.A.; Arkenbout E.K.; Pannekoek H.; de Vries C.J.

Stem cell-derived angiogenic/vasculogenic cells: Possible therapies for tissue repair and tissue engineering
pp. 900-908(9)
Authors: Zwaginga J.; Doevendans P.

Book Review
pp. 909-909(1)